These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23549927)

  • 1. Mapping CushingQoL scores onto SF-6D utility values in patients with Cushing's syndrome.
    Roset M; Badia X; Forsythe A; Webb SM
    Patient; 2013; 6(2):103-11. PubMed ID: 23549927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN).
    Badia X; Roset M; Valassi E; Franz H; Forsythe A; Webb SM
    Qual Life Res; 2013 Dec; 22(10):2941-50. PubMed ID: 23539468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric evaluation of the Cushing's Quality-of-Life questionnaire.
    Nelson LM; Forsythe A; McLeod L; Pulgar S; Maldonado M; Coles T; Zhang Y; Webb SM; Badia X
    Patient; 2013; 6(2):113-24. PubMed ID: 23575965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
    Richardson SS; Berven S
    Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire.
    Webb SM; Badia X; Barahona MJ; Colao A; Strasburger CJ; Tabarin A; van Aken MO; Pivonello R; Stalla G; Lamberts SW; Glusman JE
    Eur J Endocrinol; 2008 May; 158(5):623-30. PubMed ID: 18426820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
    Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
    Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.
    Kalaitzakis E; Benito de Valle M; Rahman M; Lindkvist B; Björnsson E; Chapman R; Kontodimopoulos N
    Qual Life Res; 2016 Apr; 25(4):947-57. PubMed ID: 26471264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the Functional Assessment of Cancer Therapy-general or -Colorectal to SF-6D in Chinese patients with colorectal neoplasm.
    Wong CK; Lam CL; Rowen D; McGhee SM; Ma KP; Law WL; Poon JT; Chan P; Kwong DL; Tsang J
    Value Health; 2012 May; 15(3):495-503. PubMed ID: 22583460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.
    Wong CK; Lam CL; Wan YF; Rowen D
    Value Health; 2013; 16(2):373-84. PubMed ID: 23538190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illustration of patient-reported outcome challenges and solutions in rare diseases: a systematic review in Cushing's syndrome.
    Knoble N; Nayroles G; Cheng C; Arnould B
    Orphanet J Rare Dis; 2018 Dec; 13(1):228. PubMed ID: 30567582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the Gastrointestinal Quality of Life Index to short-form 6D utility scores.
    Lee L; Kaneva P; Latimer E; Feldman LS
    J Surg Res; 2014 Jan; 186(1):135-41. PubMed ID: 24021906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia.
    Abdin E; Chong SA; Seow E; Verma S; Tan KB; Subramaniam M
    Qual Life Res; 2019 Jan; 28(1):177-186. PubMed ID: 30382480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using subscales when scoring the Cushing's quality of life questionnaire.
    Tiemensma J; Depaoli S; Felt JM
    Eur J Endocrinol; 2016 Jan; 174(1):33-40. PubMed ID: 26431845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the cancer-specific FACT-B onto the generic SF-6Dv2.
    Nahvijou A; Safari H; Yousefi M; Rajabi M; Arab-Zozani M; Ameri H
    Breast Cancer; 2021 Jan; 28(1):130-136. PubMed ID: 32712768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the Performance of 2 Health Utility Measures in the Medicare Health Outcome Survey (HOS).
    Jia H; Lubetkin EI; DeMichele K; Stark DS; Zack MM; Thompson WW
    Med Decis Making; 2018 Nov; 38(8):983-993. PubMed ID: 30403580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting SF-6D utility scores from the Oswestry disability index and numeric rating scales for back and leg pain.
    Carreon LY; Glassman SD; McDonough CM; Rampersaud R; Berven S; Shainline M
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2085-9. PubMed ID: 19730215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.